Deutsche Bank AG Grows Stock Position in Aspen Aerogels, Inc. (NYSE:ASPN)

Deutsche Bank AG lifted its stake in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 37.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 415,391 shares of the construction company's stock after buying an additional 112,241 shares during the quarter. Deutsche Bank AG owned approximately 0.51% of Aspen Aerogels worth $4,935,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of ASPN. AlphaQuest LLC boosted its position in Aspen Aerogels by 54.0% during the fourth quarter. AlphaQuest LLC now owns 11,395 shares of the construction company's stock worth $135,000 after purchasing an additional 3,998 shares in the last quarter. KLP Kapitalforvaltning AS purchased a new position in Aspen Aerogels during the fourth quarter worth approximately $164,000. Connors Investor Services Inc. purchased a new position in Aspen Aerogels during the fourth quarter worth approximately $168,000. Journey Strategic Wealth LLC purchased a new position in Aspen Aerogels during the fourth quarter worth approximately $178,000. Finally, Ballentine Partners LLC boosted its position in Aspen Aerogels by 19.2% during the fourth quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company's stock worth $189,000 after purchasing an additional 2,565 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Aspen Aerogels Price Performance

Shares of NYSE:ASPN traded down $0.01 during midday trading on Friday, hitting $6.41. The company had a trading volume of 3,824,375 shares, compared to its average volume of 1,998,049. Aspen Aerogels, Inc. has a twelve month low of $4.16 and a twelve month high of $33.15. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. The stock has a market cap of $526.29 million, a price-to-earnings ratio of 40.07 and a beta of 2.72. The business's 50-day simple moving average is $5.80 and its 200-day simple moving average is $9.67.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The construction company reported ($0.06) EPS for the quarter, beating the consensus estimate of ($0.07) by $0.01. The firm had revenue of $78.72 million during the quarter, compared to analysts' expectations of $82.75 million. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. The business's revenue for the quarter was down 16.7% on a year-over-year basis. During the same quarter last year, the firm earned ($0.02) earnings per share. On average, research analysts predict that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Roth Mkm lowered their price target on Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. B. Riley decreased their target price on Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating on the stock in a research report on Wednesday, February 19th. Barclays decreased their target price on Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating on the stock in a research report on Wednesday, February 19th. Oppenheimer downgraded Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research report on Thursday, May 8th. Finally, Wall Street Zen upgraded Aspen Aerogels to a "sell" rating in a research report on Wednesday, February 19th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $19.11.

Insiders Place Their Bets

In other Aspen Aerogels news, CEO Donald R. Young bought 20,000 shares of the business's stock in a transaction on Monday, May 12th. The stock was bought at an average price of $5.35 per share, with a total value of $107,000.00. Following the completion of the purchase, the chief executive officer now directly owns 550,856 shares in the company, valued at $2,947,079.60. The trade was a 3.77% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 4.30% of the stock is owned by insiders.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.